Axonal Damage in Relapsing Multiple Sclerosis is Markedly Reduced by Natalizumab

@inproceedings{Minagar2011AxonalDI,
  title={Axonal Damage in Relapsing Multiple Sclerosis is Markedly Reduced by Natalizumab},
  author={Alireza Minagar},
  year={2011}
}

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 118 CITATIONS

Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis.

  • Brain : a journal of neurology
  • 2014
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis.

  • Acta neurologica Scandinavica
  • 2013
VIEW 5 EXCERPTS
CITES METHODS, RESULTS & BACKGROUND
HIGHLY INFLUENCED

The Cerebrospinal Fluid in Multiple Sclerosis

VIEW 6 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2010
2019

CITATION STATISTICS

  • 9 Highly Influenced Citations

  • Averaged 15 Citations per year over the last 3 years

  • 10% Increase in citations per year in 2018 over 2017

Similar Papers

Loading similar papers…